Lucentis for Inflammatory Macular Edema Trial

NCT00498355 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Uveitis
Cytoid Macular Edema

Interventions

DRUG: Ranibizumab

Sponsor

University of California, San Francisco

Collaborators

[object Object]